Live Breaking News & Updates on Andrew Craig Miller

Stay updated with breaking news from Andrew craig miller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Karuna Therapeutics, Inc. (NASDAQ:KRTX) Shares Bought by China Universal Asset Management Co. Ltd.

China Universal Asset Management Co. Ltd. boosted its holdings in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) by 34.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 468 shares of the company’s stock after acquiring an additional […] ....

Troya Ignelzi , Andrew Craig Miller , Almanack Investment Partners , Jpmorgan Chase Co , Karuna Therapeutics Inc , Advisors Inc , Exchange Traded Concepts , China Universal Asset Management Co , Securities Exchange Commission , China Universal Asset Management , Karuna Therapeutics , Free Report , Universal Asset Management , Investment Partners , Craig Miller , Exchange Commission , Get Free Report , Visit Holdingschannel , Karuna Therapeutics Daily ,

Karuna Therapeutics, Inc. (NASDAQ:KRTX) Receives $275.44 Consensus Target Price from Brokerages

Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fifteen brokerages that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1 year […] ....

United Kingdom , Lauriej Olson , Andrew Craig Miller , Cambridge Investment Research Advisors Inc , Metlife Investment Management , York Mellon Corp , Karuna Therapeutics Inc , Jpmorgan Chase Co , Karuna Therapeutics , Get Free Report , Director Laurie , Craig Miller , New York Mellon Corp , Investment Research Advisors , Life Investment Management , Rhumbline Advisers , Get Free , Karuna Therapeutics Daily ,

FY2025 EPS Estimates for Karuna Therapeutics, Inc. (NASDAQ:KRTX) Lowered by Analyst

Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) – Investment analysts at Zacks Research lowered their FY2025 EPS estimates for Karuna Therapeutics in a research note issued on Thursday, June 15th. Zacks Research analyst S. Ganoria now forecasts that the company will earn ($5.07) per share for the year, down from their previous forecast of ($4.81). […] ....

New York , United States , Peter Jeffrey Conn , Andrew Miller , Andrew Craig Miller , Lauriej Olson , Eric Elenko , Capital Impact Advisors , York State Common Retirement Fund , Cantor Fitzgerald , International Biotechnology Trust , Zacks Research , Karuna Therapeutics Inc , Wells Fargo Company , Prelude Capital Management , Ameriprise Financial Inc , Securities Exchange Commission , Karuna Therapeutics , Get Rating , Karuna Therapeutic , Therapeutics Trading Down , Capital Management , Impact Advisors , Craig Miller , Exchange Commission , Director Laurie ,

Brokerages Set Karuna Therapeutics, Inc. (NASDAQ:KRTX) PT at $275.44

Shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) have been given a consensus recommendation of “Moderate Buy” by the fifteen ratings firms that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 12-month price […] ....

United States , Peter Jeffrey Conn , Eric Elenko , Andrew Miller , Troya Ignelzi , Andrew Craig Miller , Sei Investments Co , Ameriprise Financial Inc , Jpmorgan Chase Co , Xponance Inc , First Horizon Advisors Inc , Karuna Therapeutics Inc , Cantor Fitzgerald , Karuna Therapeutics Company Profile , Karuna Therapeutics , Get Rating , Craig Miller , Horizon Advisors , Amalgamated Bank , Karuna Therapeutics Daily ,